ChemoMetec A/S

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 15:59:41 08/05/2024 BST			5-day change	1st Jan Change
312.8 ^DKK	-0.64%		+6.11%	-19.38%

04-12	Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	CI
04-12	ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	CI

Chemometec A/S Provides Earnings Guidance for the 2023-2024 Financial Year

September 13, 2023 at 06:45 pm

Chemometec A/S provided earnings guidance for the 2023-2024 financial year. For the period, company expects revenue in the range of DKK 400 Million - 435 million (2022-2023: DKK 442.3 million).

Latest news about ChemoMetec A/S

Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	04-12	CI
ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	04-12	CI
ChemoMetec Appoints COO as New CEO	03-13	MT
ChemoMetec A/S Announces CEO Changes	03-13	CI
Transcript : ChemoMetec A/S, H1 2024 Earnings Call, Feb 06, 2024	02-06
ChemoMetec A/S Maintains Earnings Guidance for the Year 2024	02-05	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2023	02-05	CI
ChemoMetec A/S Announces Executive Changes	12-20	CI
Transcript : ChemoMetec A/S, 2023 Earnings Call, Sep 14, 2023	14/09/23
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2023	13/09/23	CI
Chemometec A/S Proposes Dividend for the 2022/23 Financial Year	13/09/23	CI
Chemometec A/S Provides Earnings Guidance for the 2023-2024 Financial Year	13/09/23	CI
ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023	08/05/23	CI
ChemoMetec A/S Appoints Rasmus Kofoed as CEO, Effective No Later Than 1 August 2023	17/04/23	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2022	08/02/23	CI
ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023	08/02/23	CI
Chemometec A/S Announces Resignation of Steen Søndergaard as CEO	14/12/22	CI
ChemoMetec A/S Provides Earnings Guidance for the Financial Year 2022-23	08/11/22	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	16/09/22	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	16/09/22	CI
ChemoMetec A/S Provides Revenue Guidance for the Fiscal Year 2023	15/09/22	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2021	08/02/22	CI
Chemometec A/S Reaffirms Earnings Guidance for the Financial Year 2021-2022	04/11/21	CI
ChemoMetec Appoints Bent Faurskov as New CFO from 1 October 2021	30/06/21	CI
Chemometec A/S Announces Unaudited Consolidated Earnings Results for the First Half Ended December 31, 2020	05/02/21	CI

Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Companyâs activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Companyâs analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.

Sector

Medical Equipment, Supplies & Distribution

Calendar

10/09/2024 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for ChemoMetec A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

312.8 DKK

Average target price

462.5 DKK

Spread / Average Target

+47.86%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
CHEMOMETEC A/S	-19.38%	784M
SHOCKWAVE MEDICAL, INC.	+73.46%	12.41B
PENUMBRA, INC.	-16.75%	7.87B
MASIMO CORPORATION	+5.93%	6.37B
GETINGE AB	+3.66%	5.81B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+13.79%	5.36B
APT MEDICAL INC.	+40.99%	4.92B
ASAHI INTECC CO., LTD.	-19.00%	4.02B
INARI MEDICAL, INC.	-34.55%	2.43B
SKAN GROUP AG	+0.74%	2.02B

Medical Equipment

ChemoMetec A/S

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Chemometec A/S Provides Earnings Guidance for the 2023-2024 Financial Year

Latest news about ChemoMetec A/S

Chart ChemoMetec A/S

Company Profile

Income Statement Evolution

Ratings for ChemoMetec A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Equipment